Simple jQuery Dropdowns

Browsing by Author Steven Self

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
1-Feb-2007Executive summary and recommendations from the WHO/UNAIDS/IAVI expert group consultation on 'Phase IIB-TOC trials as a novel strategy for evaluation of preventive HIV vaccines', 31 January-2 February 2006, IAVI, New York, USAJim Ackland; Susan Allen; Daniel Barth-Jones; Deborah Birx; Elwyn Chomba; Gavin Churchyard; Ann Duerr; Shuigao Jin; Margaret Johnston; Patricia E. Fast; Alan Fix; Mary Foulkes; Dean Follmann; Raymond Hutubessy; Siobhan Malone; Ronald Gray; Abhay Indrayan; Jonathan Levin; Bonnie J. Mathieson; Timothy D. Mastro; John McNeil; Saladin Osmanov; Punnee Pitisuttithum; Barry Peters; Etienne Karita; Michael N. Robertson; R. Ramakrishnan; Helen Rees; Wasima Rida; Yuhua Ruan; Eric Sandström; Claudia Schmidt; Peter Smith; Steven Self; Georges Thiry; Judith Wasserheit; Frances Priddy; Ibou Thior; Mitchell Warren; David Cooper; Pontiano Kaleebu; Ruth Macklin; Godfrey Tangwa; Global BioSolutions; Rollins School of Public Health; Wayne State University School of Medicine; Centers for Disease Control and Prevention; Zambia-UAB HIV Research Project; Ernest Oppenheimer Hospital; Scientific Support Unit; Chinese Center for Disease Control and Prevention; National Institute of Allergy and Infectious Diseases; International AIDS Vaccine Initiative; Food and Drug Administration; Organisation Mondiale de la Sante; Bill and Melinda Gates Foundation; Johns Hopkins Bloomberg School of Public Health; University College of Medical Sciences; South African Medical Research Council; OAR HIV/AIDS Vaccine Coordinating Committee; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention; Mahidol University; Guy's and St Thomas' NHS Foundation Trust; Projet San Francisco Rwanda; Merck & Co., Inc.; National Institute of Epidemiology; University of Witwatersrand; Statistics Collaborative; Karolinska University Hospital; London School of Hygiene & Tropical Medicine; Statistical Center for HIV/AIDS Research and Prevention; IAVI; HIV Vaccine Trials Network; Emory University; Botswana Harvard AIDS Institute Partnership; AIDS Vaccine Advocacy Coalition; Kirby Institute; Uganda Virus Research Institute; Albert Einstein College of Medicine of Yeshiva University; Universite de Yaounde I
1-May-2011Safety and immunogenicity of the MRKAd5 gag HIV type 1 vaccine in a worldwide phase 1 study of healthy adultsOuzama Nicholson; Fay Dicandilo; James Kublin; Xiao Sun; Erin Quirk; Michelle Miller; Glenda Gray; Jean Pape; Michael N. Robertson; Devan V. Mehrotra; Steven Self; Katherine Turner; Jorge Sanchez; Punnee Pitisuttithum; Ann Duerr; Sheri Dubey; Lisa Kierstead; Danilo Casimiro; Scott M. Hammer; Merck & Co., Inc.; GlaxoSmithKline, USA; Fred Hutchinson Cancer Research Center; University of Witwatersrand; Weill Cornell Medical College; Asociación Civil Impacta Salud y Educación; Investigaciones Medicas en Salud; Mahidol University; University of Washington, Seattle; Columbia University in the City of New York